Gene therapy in cardiovascular disorder market is estimated to be worth US$ 178 million in 2023 and is projected to reach US$ 1,351.3 million by 2030, growing at a CAGR of 21.1% during the forecast period 2024-2030. This significant growth is driven by factors such as rising prevalence of cardiovascular diseases, increasing investments in gene therapy research and development, and growing...

  The Hemophilia Market Research Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Hemophilia Market Growth from 2025 to 2032, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry...

The Hemophilia Market size was valued at USD 13.62 billion in 2022 and is expected to reach USD 20.43 billion by 2030 and grow at a CAGR of 5.2 % over the forecast period of 2023-2030. Key Drivers of Market Expansion: Rising Awareness and Early Diagnosis: Increased public awareness and improved diagnostic tools lead to earlier diagnoses and interventions, improving patient...